MECHI, CLAUDIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 927
EU - Europa 545
AS - Asia 234
AF - Africa 1
SA - Sud America 1
Totale 1.708
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 926
PL - Polonia 172
IE - Irlanda 119
IT - Italia 104
CN - Cina 74
SE - Svezia 68
HK - Hong Kong 56
JO - Giordania 48
SG - Singapore 26
RU - Federazione Russa 16
DE - Germania 13
GB - Regno Unito 12
SA - Arabia Saudita 12
FR - Francia 9
IN - India 7
UA - Ucraina 7
BE - Belgio 6
CH - Svizzera 6
FI - Finlandia 6
IR - Iran 5
GR - Grecia 3
KR - Corea 3
NL - Olanda 2
VN - Vietnam 2
AT - Austria 1
BR - Brasile 1
CA - Canada 1
LT - Lituania 1
SC - Seychelles 1
TR - Turchia 1
Totale 1.708
Salva come PNG Salva come JPEG
Città #
Warsaw 172
Chandler 132
Fairfield 120
Dublin 119
Ashburn 76
Seattle 55
Woodbridge 46
Houston 45
Ann Arbor 43
Beijing 43
Cambridge 40
Wilmington 37
Hong Kong 34
Lawrence 34
Altamura 32
Princeton 27
Florence 23
Milan 23
Buffalo 22
Kent 21
Boston 19
Shanghai 19
New York 16
Singapore 16
Riyadh 12
Dearborn 10
Moscow 9
San Diego 9
Jacksonville 7
Medford 7
Norwalk 7
Bern 6
Brussels 6
West Jordan 6
Forlì 4
Seoul 3
Thessaloniki 3
Chennai 2
Dong Ket 2
Falls Church 2
Forney 2
Hefei 2
Jinan 2
Lappeenranta 2
London 2
Mumbai 2
Nanjing 2
Palermo 2
Pune 2
Redwood City 2
Salerno 2
Auburn Hills 1
Berlin 1
Bielefeld 1
Boardman 1
Bremen 1
Carate Brianza 1
Chengdu 1
Frankfurt am Main 1
Hanover 1
Helsinki 1
Hyderabad 1
Islington 1
Istanbul 1
Kunming 1
Naaldwijk 1
Naples 1
Phoenix 1
Pontassieve 1
Redmond 1
Rome 1
Shenzhen 1
Southwark 1
São Paulo 1
Toronto 1
Verona 1
Vienna 1
Vilnius 1
Wenzhou 1
Wuhan 1
Totale 1.360
Salva come PNG Salva come JPEG
Nome #
Markers of JC virus infection in patients with multiple sclerosis under natalizumab therapy. 218
Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study 123
Safety and efficacy of autologous hematopoietic stem cell transplantation following natalizumab discontinuation in aggressive Multiple Sclerosis. 103
Disease reactivation following fingolimod withdrawal in multiple sclerosis: Two case reports. 99
Clinical characteristics predicting relapses following disease modifying therapies discontinuation in multiple sclerosis: a monocentric cohort study 85
Clinical and genetic characteristics of late-onset Huntington's disease 80
Suicidal ideation in a European Huntington's disease population 79
Human fetal striatal transplantation in disease. First italian clinic trial at the University of Florence. Preliminare Report 67
The diagnosis of multiple sclerosis with markers of "better explanation": accuracy of the "central vein sign" in uncovering pathogenic mechansms different from inflammatory demyelination 63
Differentiation by MRI between multiple sclerosis and MS-like syndromes with markers of "better explanation" of the diagnosis. 62
Effect of disease-modifying treatments on antibody-mediated response to anti- COVID19 vaccination in people with multiple sclerosis 62
Susceptibility weighted MRI can help differentiating pathogenesis of white matter lesions in MS and CNS inflammatory vasculopathies. 60
Accuracy of the central vein sign evaluation by brain MRI for the pathologic characterization of multiple sclerosis cases with markers of "better explanation" of the diagnosis. 57
Impact of autologous haematopoietic stem cell transplantation on disability and brain atrophy in secondary progressive multiple sclerosis 57
Intermediate-Intensity Autologous Hematopoietic Stem Cell Transplantation Reduces Serum Neurofilament Light Chains and Brain Atrophy in Aggressive Multiple Sclerosis. 43
Imaging perivenular distribution can differentiate MS from CNS vasculitis. 42
Leptomeningeal enhancement analysis in diagnostic clinical setting 42
Real Life comparative evaluation of dimethyl fumarate efficacy and tolerability in relapsing remitting multiple sclerosis patients switching from other treatments 41
Brain atrophy evaluation in multiple sclerosis: change over time of corpus callosum area is more sensitive and reproducible than whole brain volume 39
Comparative long term efficacy of beta interferons and azathioprine in relapsing-remitting Multiple sclerosis: single center retrospective 25 year evaluation 39
Autologous hematopoietic stem cell transplantation versus low-dose immunosuppression in secondary-progressive multiple sclerosis 39
CNS inflammation during relapsing remitting multiple sclerosis (RRMS): a molecular and cellular analysis of ex vivo CSF T lymphocyte expansions 38
Sustained disease remission after discontinuation of disease modifying treatments in relapsing-remitting multiple sclerosis. 38
Clinical and paraclinical findings in a case series of MOGAD: Exploring the presence of perivenular brain white matter lesions 36
Soluble factor profile in Natalizumab treated MS patients: increased Th1 promoting factors and sHLAg 36
Evaluation of dimethyl fumarate efficacy and safety in patients with relapsing remitting multiple sclerosis switching from other treatments 35
Incidence of malignant neoplasms and mortality in people affected by multiple sclerosis in the epoch of disease-modifying treatments: a population-based study on Tuscan residents 31
K index improves MS diagnosis and supports the differential diagnosis between MS and MS-like syndromes. 25
Safety and effectiveness of the booster dose of mRNA COVID-19 vaccines in people with multiple sclerosis: A monocentric experience 22
Totale 1.761
Salva come PNG Salva come JPEG
Categoria #
all - tutte 6.568
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.568
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020315 15 9 11 31 38 27 42 33 25 47 29 8
2020/2021196 11 18 4 25 38 26 8 14 17 18 9 8
2021/2022176 4 15 11 10 0 10 7 21 9 9 28 52
2022/2023561 40 89 39 23 37 106 69 29 102 0 18 9
2023/2024284 11 32 31 18 22 27 13 45 4 32 30 19
2024/202531 31 0 0 0 0 0 0 0 0 0 0 0
Totale 1.761